How the practice of allergy shows the promise and challenge of personalized medicine

被引:10
作者
McGhee, Sean A. [1 ]
机构
[1] Dept Pediat Immunol & Allergy, Stanford, CA 94305 USA
关键词
Personalized medicine; Allergy; Cost-effectiveness; Patient safety; HUMAN BETA(2)-ADRENERGIC RECEPTOR; STEP-UP THERAPY; ASPIRIN DESENSITIZATION; BETA-2-ADRENERGIC RECEPTOR; IMMUNOLOGY MAINTENANCE; SYSTEMIC REACTIONS; AMERICAN BOARD; BETA-AGONISTS; ASTHMA; POLYMORPHISMS;
D O I
10.1016/j.ymgme.2011.07.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Personalized medicine seeks to stratify therapies according to individual characteristics, and by so doing improve effectiveness and reduce complications. However, there are not many models of care that is highly stratified within a single diagnosis in this manner. One potential model is the practice of allergy, in which care is tailored to specific allergens for individual patients within the broader context of care for rhinitis or asthma. Allergists have already confronted many of the same regulatory issues anticipated for personalized medicine. The history of allergy practice also anticipates some of the patient safety concerns that may arise from tracking and using highly personalized medical information. Finally, the therapy of allergy and asthma has been at the forefront of attempts to incorporate pharmacogenomics information into patient care. Individualized therapy has always been central to the practice of allergy, and so provides a useful proving ground for personalized medicine as a concept of care. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 41 条
[1]  
[Anonymous], 2011, ALL
[2]   Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol [J].
Basu, Kaninika ;
Palmer, Colin N. A. ;
Tavendale, Roger ;
Lipworth, Brian J. ;
Mukhopadhyay, Somnath .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (06) :1188-1194
[3]   Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease [J].
Berges-Gimeno, MP ;
Simon, RA ;
Stevenson, DD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (01) :180-186
[4]   The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions [J].
Berges-Gimeno, MP ;
Simon, RA ;
Stevenson, DD .
CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (10) :1491-1496
[5]  
Bernstein D.I., 2011, IMMUNOL ALLERGY CLIN, V31, pviii
[6]   Systemic Reactions to Subcutaneous Allergen Immunotherapy [J].
Bernstein, David I. ;
Epstein, Tolly .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2011, 31 (02) :241-+
[7]   Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma [J].
Chung, L. P. ;
Waterer, G. ;
Thompson, P. J. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (03) :312-326
[8]   New approaches to molecular cancer therapeutics [J].
Collins, Ian ;
Workman, Paul .
NATURE CHEMICAL BIOLOGY, 2006, 2 (12) :689-700
[9]   The RNA infrastructure: dark matter of the eukaryotic cell? [J].
Collins, Lesley J. ;
Penny, David .
TRENDS IN GENETICS, 2009, 25 (03) :120-128
[10]   Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities [J].
Conti, Rena ;
Veenstra, David L. ;
Armstrong, Katrina ;
Lesko, Lawrence J. ;
Grosse, Scott D. .
MEDICAL DECISION MAKING, 2010, 30 (03) :328-340